Glenmark Life Sciences Q1 Results FY26: Q1 PAT Rises 9.02% to ₹121.54 Crore; Revenue Surged 2.25% YoY

Glenmark Life Sciences Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

Glenmark Life Sciences Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• Glenmark Life Sciences clocked Q1 FY26 standalone revenue of ₹601.85 crores vs ₹588.62 crores. 
• On the profit front, Glenmark Life Sciences earned a consolidated PAT of ₹121.54 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹111.48 crore. 
• As per the standalone figures, the quarterly PAT of Glenmark Life Sciences has increased by 9.02% and revenue has increased by 2.25% YoY.

Glenmark Life Sciences Share Price Performance

On the opening bell of 4th August 2025, the shares of Glenmark Life Sciences opened at ₹987.60 per share. However, the initial gains are wiped out as of now, and Glenmark Life Sciences shares are trading at ₹965.50 per share, lower than their opening price. 

Considering the long-term performance, Glenmark Life Sciences shares have yielded close to -12.60% returns in the past 1 year, and 5-year returns stand at -15.99%. Over the maximum timeframe, the Glenmark Life Sciences share provided -15.99% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Glenmark Life Sciences shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Jyoti Global Plast IPO GMP: Day 1 IPO Live Updates

Essex Marine IPO GMP & Review: Apply or Avoid?

BLT Logistics IPO GMP & Review: Apply or Avoid?

RR Kabel Q1 Results FY26: Q1 PAT Jumps 39.44% to ₹89.77 Crore; Revenue Surged 13.85% YoY

Kirlosker Brothers Q1 Results FY26: Q1 PAT Soars 2.46% to ₹66.70 Crore; Revenue Declined 5.03% YoY

Aaradhya Disposal IPO GMP & Review: Apply or Avoid?

Aarti Industries Q1 Results FY26: Q1 PAT Down 68.61% to ₹43.00 Crore; Revenue Declined 9.45% YoY